EMEA-001072-PIP01-10-M02

  • Email
  • Help

Overview

Product details for Lemtrada
Invented nameLemtrada
Active substance

Alemtuzumab

Decision numberP/0170/2016
PIP numberEMEA-001072-PIP01-10-M02
Pharmaceutical form(s)Concentrate for solution for infusion
Condition(s)/indication(s)

Treatment of Multiple Sclerosis

Route(s) of administrationIntravenous use
PIP applicant

Genzyme Europe B.V.
The Netherlands
Tel. + 31 356991499
E-mail: eumedinfo@genzyme.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision

Related information